Allergies Conference 2014
July 9 - 10, 2014
london , United Kingdom
The launch event for Allergies is here and will be taking place on 9th July and 10th July 2014 in Central London.
The market for Allergies is expected to reach $14.7 billion by 2015. As companies look to develop different compounds and antibodies to treat allergies, our 2014 event marks the path forward in terms of allergies within personalised medicines and beyond.
The conference will examine advances in biology of biologic diseases; novel therapeutics in allergy treatment; regulation concerning updates in allergen-immunotherapy; managing food allergies; and new advances in the personalised medicine arena in allergies.
Allergies 2014 will bring together industry specialists and senior medical directors and give them a more in depth insight in to the advances in biology of biological diseases. This will be a great way for professionals in the medical sector to put across different ideas and gain some knowledge on the aspects of tackling this allergy dilemma.
Key Speakers:
• Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GSK
• Professor Alf Lindberg, Non-Executive Director, Swecure
• Dr Glenis Scadding, Consultant, Royal National Throat, Nose and Ear Hospital
• Dr Diana Church, Allergy Specialist, The Artemisia Clinic
• Professor Rudolf Valenta, Professor for Allergology, Medical University of Vienna
• Dr Suranjith Seneviratne, Consultant in Clinical Immunology and Allergy, Royal Free Hospital London
Reasons to Attend:
• Key case study presentation from GSK on new therapeutic tools for allergies
• Clinician’s perspective – advances in allergy diagnostics featuring Royal Free Hospital and The
Artemisia Clinic
• Allergy specialists – Dr Scadding and Dr Church present on new research and findings
The market for Allergies is expected to reach $14.7 billion by 2015. As companies look to develop different compounds and antibodies to treat allergies, our 2014 event marks the path forward in terms of allergies within personalised medicines and beyond.
The conference will examine advances in biology of biologic diseases; novel therapeutics in allergy treatment; regulation concerning updates in allergen-immunotherapy; managing food allergies; and new advances in the personalised medicine arena in allergies.
Allergies 2014 will bring together industry specialists and senior medical directors and give them a more in depth insight in to the advances in biology of biological diseases. This will be a great way for professionals in the medical sector to put across different ideas and gain some knowledge on the aspects of tackling this allergy dilemma.
Key Speakers:
• Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GSK
• Professor Alf Lindberg, Non-Executive Director, Swecure
• Dr Glenis Scadding, Consultant, Royal National Throat, Nose and Ear Hospital
• Dr Diana Church, Allergy Specialist, The Artemisia Clinic
• Professor Rudolf Valenta, Professor for Allergology, Medical University of Vienna
• Dr Suranjith Seneviratne, Consultant in Clinical Immunology and Allergy, Royal Free Hospital London
Reasons to Attend:
• Key case study presentation from GSK on new therapeutic tools for allergies
• Clinician’s perspective – advances in allergy diagnostics featuring Royal Free Hospital and The
Artemisia Clinic
• Allergy specialists – Dr Scadding and Dr Church present on new research and findings
Related events
Allergies Conference July 6 - 7, 2017
Allergies Conference July 6 - 7, 2016
Allergies Conference July 9 - 10, 2014
